These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23852423)
1. Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity. Benbrook DM; Guruswamy S; Wang Y; Sun Z; Mohammed A; Zhang Y; Li Q; Rao CV Cancer Prev Res (Phila); 2013 Sep; 6(9):908-16. PubMed ID: 23852423 [TBL] [Abstract][Full Text] [Related]
2. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model. Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta. Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006 [TBL] [Abstract][Full Text] [Related]
4. Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Benbrook DM; Janakiram NB; Chandra V; Pathuri G; Madka V; Stratton NC; Masamha CP; Farnsworth CN; Garcia-Contreras L; Hatipoglu MK; Lighfoot S; Rao CV Invest New Drugs; 2018 Aug; 36(4):561-570. PubMed ID: 29273857 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention. Mohammed A; Janakiram NB; Li Q; Choi CI; Zhang Y; Steele VE; Rao CV Cancer Prev Res (Phila); 2011 Dec; 4(12):2015-26. PubMed ID: 21885812 [TBL] [Abstract][Full Text] [Related]
6. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis. Mohammed A; Janakiram NB; Brewer M; Vedala K; Steele VE; Rao CV Neoplasia; 2013 May; 15(5):481-90. PubMed ID: 23633920 [TBL] [Abstract][Full Text] [Related]
7. Development of flexible-heteroarotinoids for kidney cancer. Liu T; Masamha CP; Chengedza S; Berlin KD; Lightfoot S; He F; Benbrook DM Mol Cancer Ther; 2009 May; 8(5):1227-38. PubMed ID: 19417155 [TBL] [Abstract][Full Text] [Related]
8. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Song J; Medline A; Mason JB; Gallinger S; Kim YI Cancer Res; 2000 Oct; 60(19):5434-40. PubMed ID: 11034085 [TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effect of ERĪ²-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice. Giroux V; Bernatchez G; Carrier JC Mol Carcinog; 2011 May; 50(5):359-69. PubMed ID: 21480389 [TBL] [Abstract][Full Text] [Related]
11. Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo. Myers T; Chengedza S; Lightfoot S; Pan Y; Dedmond D; Cole L; Tang Y; Benbrook DM Invest New Drugs; 2009 Aug; 27(4):304-18. PubMed ID: 18802666 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Rajamanickam S; Velmurugan B; Kaur M; Singh RP; Agarwal R Cancer Res; 2010 Mar; 70(6):2368-78. PubMed ID: 20215518 [TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice. Janakiram NB; Mohammed A; Qian L; Choi CI; Steele VE; Rao CV Neoplasia; 2012 Feb; 14(2):159-68. PubMed ID: 22431924 [TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490 [TBL] [Abstract][Full Text] [Related]
16. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in Apc Saxena A; Tammali R; Ramana KV; Srivastava SK Curr Cancer Drug Targets; 2018; 18(9):905-911. PubMed ID: 28786349 [TBL] [Abstract][Full Text] [Related]
17. Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation. Cheung KL; Lee JH; Khor TO; Wu TY; Li GX; Chan J; Yang CS; Kong AN Mol Carcinog; 2014 Jan; 53(1):77-84. PubMed ID: 22911891 [TBL] [Abstract][Full Text] [Related]
18. The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC(Min/+) mice. Wang R; Wang Y; Gao Z; Qu X Drug Discov Ther; 2014 Feb; 8(1):25-32. PubMed ID: 24647155 [TBL] [Abstract][Full Text] [Related]
19. Sunitinib malate inhibits intestinal tumor development in male Apc Chen L; Xu P; Xiao Q; Chen L; Li S; Jian JM; Zhong YB Int Immunopharmacol; 2021 Jan; 90():107128. PubMed ID: 33191180 [TBL] [Abstract][Full Text] [Related]
20. Regulation of stromal cell cyclooxygenase-2 in the ApcMin/+ mouse model of intestinal tumorigenesis. Hull MA; Faluyi OO; Ko CW; Holwell S; Scott DJ; Cuthbert RJ; Poulsom R; Goodlad R; Bonifer C; Markham AF; Coletta PL Carcinogenesis; 2006 Mar; 27(3):382-91. PubMed ID: 16219637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]